Replacement of aprotinin by tranexamic acid during on-pump cardiac surgery: A retrospective evaluation of clinical outcome and cost-effectiveness

Aims: The antifibrinolytics aprotinin and tranexamic acid (TXA) are established blood saving agents in surgical treatment including cardiac surgery. Methods: Because of the anticipated better risk/benefit ratio of TXA the established antifibrinolytic treatment with aprotinin was replaced by a TXA tr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Roth, M, Schönburg, M, Poetzsch, B, Madlener, K
Format:	Tagungsbericht
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!